San Francisco, California, May 05, 2017: TMR Research discusses the future of the global predictive genetic testing and consumer/wellness in its comprehensive research report. The publication, titled “Predictive Genetic Testing and Consumer/Wellness Genomics Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” offers an extensive explanation of the various market drivers responsible for shaping the future of the overall market. The research report states that the growing interest in the study of human gene and the alterations it has gone through over the years has propelled the growth of the global predictive genetic testing and consumer/wellness genomics market.
The growing demand for predictive testing is attributable to the increasing interest in identifying the gene mutations that result in disorders and diseases. The rising pool of people with various types of conditions has also spiked an interest this type of testing as it helps in ascertaining the risk of diseases and their severity. Analysts expect the global market to thrive as effective implementation and usage of predictive testing are expected to change the methods of disease management, thereby giving the healthcare sector an additional boost. Users will be able to gain an insightful assessment of various types of cancer, autism, and heart diseases and their impact on the progeny, thereby allowing preventive care a fair chance.
Growing number of collaborations between big players and research institutes are expected to be the primary growth driver for the global market. The market is also likely to benefit from the plummeting costs of genetic sequencing and introduction of point-solutions in the field of genomics. Rapid technological advancements with integration of cloud solutions and data integration have also been identified as important factors likely to promote the growth of the global market.
The types of tests available in the global predictive genetic testing and consumer/wellness genomics market are predictive testing, consumer genomics and wellness genetics. The predictive testing offers tests such as predictive diagnostics, genetic susceptibility test, and population screening programs. On the other hand, the wellness genetics includes tests such as nutria genetics, metabolism genetics, and skin among others.
Some of the key players operating in the global predictive genetic testing and consumer/wellness genomics market are BGI, 23andMe, Inc, Illumina, Inc, Genesis Genetics, Myriad Genetics, Inc, Pathway Genomics, ARUP Laboratories, and Color Genomics Inc. The research report offers a thorough outlook of the competitive landscape present in the global market along with the assessment of the threat from new entrants and substitutes. The publication also evaluates the research and development strategies of these players, their financial outlook, and their business and marketing plans for the forecast period.